Fund profile
Fund manager
Total assets
$12.25 mm
Liabilities
$45.89 k
Net assets
$12.20 mm
Number of holdings
67.00
67 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ABBV Abbvie Inc | 950.43 k | 6.13 k shares | 7.79 | Common equity | Long | USA |
AMGN AMGEN Inc. | 718.61 k | 2.50 k shares | 5.89 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 555.81 k | 1.37 k shares | 4.56 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 532.72 k | 6.58 k shares | 4.37 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 518.19 k | 590.00 shares | 4.25 | Common equity | Long | USA |
MRNA Moderna Inc | 367.07 k | 3.69 k shares | 3.01 | Common equity | Long | USA |
BIIB Biogen Inc | 357.88 k | 1.38 k shares | 2.93 | Common equity | Long | USA |
CTVA Corteva Inc | 336.78 k | 7.03 k shares | 2.76 | Common equity | Long | USA |
AstraZeneca plc
|
319.31 k | 4.74 k shares | 2.62 | Common equity | Long | UK |
ILMN Illumina Inc | 284.89 k | 2.05 k shares | 2.33 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 284.24 k | 1.49 k shares | 2.33 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 248.05 k | 2.97 k shares | 2.03 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 242.21 k | 2.51 k shares | 1.99 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 219.13 k | 2.96 k shares | 1.80 | Common equity | Long | USA |
VTRS Viatris Inc | 212.42 k | 19.61 k shares | 1.74 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 209.37 k | 1.59 k shares | 1.72 | Common equity | Long | USA |
Royalty Pharma plc
|
208.99 k | 7.44 k shares | 1.71 | Common equity | Long | USA |
INCY Incyte Corp. | 206.14 k | 3.28 k shares | 1.69 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 186.65 k | 3.10 k shares | 1.53 | Common equity | Long | Cayman Islands |
UTHR United Therapeutics Corp | 171.29 k | 779.00 shares | 1.40 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 170.49 k | 1.77 k shares | 1.40 | Common equity | Long | USA |
Alkermes plc
|
166.36 k | 6.00 k shares | 1.36 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 159.34 k | 5.37 k shares | 1.31 | Common equity | Long | USA |
EXEL Exelixis Inc | 158.79 k | 6.62 k shares | 1.30 | Common equity | Long | USA |
NTRA Natera Inc | 155.72 k | 2.49 k shares | 1.28 | Common equity | Long | USA |
Jazz Pharmaceuticals plc
|
155.72 k | 1.27 k shares | 1.28 | Common equity | Long | USA |
Novocure Ltd.
|
155.62 k | 10.42 k shares | 1.28 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 154.27 k | 2.15 k shares | 1.26 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 151.06 k | 2.99 k shares | 1.24 | Common equity | Long | USA |
BNTX BioNTech SE | 142.27 k | 1.35 k shares | 1.17 | Common equity | Long | Germany |
MEDP Medpace Holdings Inc | 140.08 k | 457.00 shares | 1.15 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 139.88 k | 3.47 k shares | 1.15 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 138.63 k | 438.00 shares | 1.14 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 134.50 k | 11.98 k shares | 1.10 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 130.94 k | 4.18 k shares | 1.07 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 130.80 k | 1.42 k shares | 1.07 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 130.20 k | 2.18 k shares | 1.07 | Common equity | Long | USA |
ARGX Argen X SE | 129.35 k | 340.00 shares | 1.06 | Common equity | Long | Netherlands |
RVMD Revolution Medicines Inc | 128.17 k | 4.47 k shares | 1.05 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
127.27 k | 2.03 k shares | 1.04 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 127.18 k | 8.96 k shares | 1.04 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 126.92 k | 2.02 k shares | 1.04 | Common equity | Long | USA |
INSM Insmed Inc | 125.20 k | 4.04 k shares | 1.03 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 118.42 k | 3.20 k shares | 0.97 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 116.97 k | 2.45 k shares | 0.96 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 112.52 k | 3.68 k shares | 0.92 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 109.69 k | 1.87 k shares | 0.90 | Common equity | Long | USA |
GH Guardant Health Inc | 100.84 k | 3.73 k shares | 0.83 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 98.83 k | 10.07 k shares | 0.81 | Common equity | Long | USA |
IMVT Immunovant Inc | 93.28 k | 2.21 k shares | 0.76 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 92.17 k | 3.02 k shares | 0.76 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 87.55 k | 1.10 k shares | 0.72 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 87.36 k | 5.12 k shares | 0.72 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 84.41 k | 10.38 k shares | 0.69 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 82.74 k | 3.00 k shares | 0.68 | Common equity | Long | USA |
Prothena Corporation plc
|
81.51 k | 2.24 k shares | 0.67 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 77.23 k | 5.52 k shares | 0.63 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 73.67 k | 6.44 k shares | 0.60 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 72.70 k | 2.67 k shares | 0.60 | Common equity | Long | USA |
TEF Telefonica S.A | 66.36 k | 2.84 k shares | 0.54 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 62.40 k | 503.00 shares | 0.51 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 61.55 k | 266.00 shares | 0.50 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 61.43 k | 2.84 k shares | 0.50 | Common equity | Long | USA |
First American Government Obligations Fund - Class X | 51.04 k | 51.04 k shares | 0.42 | Short-term investment vehicle | Long | USA |
NVAX Novavax, Inc. | 38.96 k | 8.12 k shares | 0.32 | Common equity | Long | USA |
J.P. Morgan Securities LLC | 31.00 k | 31.00 k principal | 0.25 | Repurchase agreement | Long | USA |
BofA Securities, Inc. | 24.98 k | 24.98 k principal | 0.20 | Repurchase agreement | Long | USA |